Document is current
Any future updates will be listed below
-
Authors
Cereja, Fátima
Alves, Mariana
Ferreira, Joaquim J
Caldeira, Daniel https://orcid.org/0000-0002-2520-5673
- License Information
-
More Information
Article History
Accepted: 5 March 2023
First Online: 25 March 2023
Declarations
:
: Dr Cereja reports no conflict of interest. Dr Alves reports participation in conferences with Boehringer-Ingelheim, AstraZeneca, Bayer, Bristol-Myers-Squibb, Grunenthal, Tecnimede, Merck Sharp & Dohme. Professor Caldeira reports participation in conferences with Bristol-Myers-Squibb, Bayer, Boheringer Ingelheim, Daiichi-Sankyo, Merck-Serono, Ferrer, Pfizer,Novartis, Roche. Professor Ferreira reports personal fees from Grunenthal, Fundacao MSD (Portugal), TEVA, MSD, Allergan, Medtronic, GlaxoSmithKline, Novartis, Lundbeck, Solvay, BIAL, Merck-Serono, Merz, Ipsen, Biogen, Acadia, Allergan, Abbvie, Sunovion-Pharmaceuticals.
: Not applicable.
: Not applicable.
